Raptiva Being Withdrawn from U.S.

Posted by PKSD Law Firm on May 12, 2009 in Dangerous Drugs

Genentech Inc., the manufacturer of the drug Raptiva, announced it has begun a voluntary, phased withdrawal of the product from the U.S. market.

The company is taking this action because of the possible risk of developing progressive multi-focal leukoencephalopathy (PML), a rare but serious brain infection. By June 8, 2009, Raptiva will no longer be available in the U.S.

PML leads to a gradual worsening in the way the nervous system works, which cannot be reversed, and death. People at risk include those who have taken Raptiva and have severely weakened immune systems.

PKSD is a Wisconsin personal injury law firm handling faulty product cases through out the state.  Our personal injury lawyers have successfully represented injured people in almost every county. We know Wisconsin.

Back to top